OTC · CREEF
Crescera Capital Acquisition Corp.
$10.94-$0.30 (-2.68%)
Crescera Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 36.21% below the high.
Loading market information…
OTC · BENH · USD
Stock price, earnings
Quote as of Jun 4, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Bio-En Holdings Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Bio-En Holdings Corp does not have significant operations and is a shell company. Previously, it focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was formerly known as Olivia Inc. and changed its name to Bio-En Holdings Corp in August 2014.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:23 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$10.94-$0.30 (-2.68%)
Crescera Capital Acquisition Corp.’s quoted price sits in the lower half of its reported 52-week range, 36.21% below the high.
$9.93$0.00 (0.0%)
Southport Acquisition Corp. II’s quoted price sits in the lower half of its reported 52-week range, 0.5% below the high.
$12.47$0.00 (0.0%)
Clover Leaf Capital Corp.’s quoted price sits in the upper half of its reported 52-week range, 15.46% below the high.
$15.50$0.00 (0.0%)
Citizens Commerce Bancshares, Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.49% below the high.
$40.00+$1.00 (+2.56%)
Cornerstone Community Bancorp’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$10.55-$11.45 (-52.05%)
Focus Impact BH3 Acquisition Co’s quoted price sits in the lower half of its reported 52-week range, 52.05% below the high.
$2.50$0.00 (0.0%)
Petrocorp Inc.’s quoted price sits in the upper half of its reported 52-week range, 37.5% below the high.
$0.50-$1.39 (-73.65%)
Artemis Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 88.93% below the high.
